Ambulatory Phlebectomy and Sclerotherapy as Tools for the Treatment of Varicose Veins and Telangiectasias

R. Hampton Andrews; Robert G. Dixon

doi:10.1055/s-0041-1727151

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2021; 38(02): 160-166
DOI: 10.1055/s-0041-1727151

Review Article

Ambulatory Phlebectomy and Sclerotherapy as Tools for the Treatment of Varicose Veins and Telangiectasias

Autor*innen

R. Hampton Andrews

¹Department of Radiology, University of North Carolina, Chapel Hill, North Carolina
Robert G. Dixon

²Interventional Radiology Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Abstract

Treatment of chronic venous disease is a fascinating and rewarding undertaking. Once the truncal reflux is addressed, several options are available that can be used to treat the associated ulcers, varicosities, reticular veins, and telangiectasias. This review will focus on two widely employed procedures: ambulatory phlebectomy and sclerotherapy.

Keywords

phlebectomy - microphlebectomy - ambulatory phlebectomy - sclerotherapy - varicose veins - telangiectasias - interventional radiology

Volltext

Referenzen

References
1 Wittens C, Davies AH, Bækgaard N. et al; ESVS Guidelines Committee. Editor's choice - management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015; 49 (06) 678-737
2 Kabnick LS, Ombrellino M. Ambulatory phlebectomy. Semin Intervent Radiol 2005; 22 (03) 218-224
3 Geersen DF, Shortell CEK. Phlebectomy techniques for varicose veins. Surg Clin North Am 2018; 98 (02) 401-414
4 Cheshire N, Elias SM, Keagy B. et al. Powered phlebectomy (TriVex) in treatment of varicose veins. Ann Vasc Surg 2002; 16 (04) 488-494
5 Muller R. Interview with Dr. Robert Muller. Father of modern day ambulatory phlebectomy. Interview by Jose A. Olivencia. Dermatol Surg 1998; 24 (10) 1147-1150
6 Muller R. [Treatment of varicose veins by ambulatory phlebectomy]. Phlebologie 1966; 19 (04) 277-279
7 Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014; 130 (04) 333-346
8 Hamdan A. Management of varicose veins and venous insufficiency. JAMA 2012; 308 (24) 2612-2621
9 Zolotukhin IA, Seliverstov EI, Zakharova EA, Kirienko AI. Short-term results of isolated phlebectomy with preservation of incompetent great saphenous vein (ASVAL procedure) in primary varicose veins disease. Phlebology 2017; 32 (09) 601-607
10 Mauro MA, Murphy KP, Thomson KR, Venbrux AC. Image-Guided Interventions: Expert Radiology Series. 3rd ed.. St. Louis, MO: Saunders; 2020: 619-624
11 Lane TRA, Kelleher D, Shepherd AC, Franklin IJ, Davies AH. Ambulatory varicosity avulsion later or synchronized (AVULS): a randomized clinical trial. Ann Surg 2015; 261 (04) 654-661
12 Patel IJ, Rahim S, Davidson JC. et al. Society of Interventional Radiology Consensus Guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—Part II: Recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 2019; 30 (08) 1168-1184.e1
13 Hager ES, Ozvath KJ, Dillavou ED. Evidence summary of combined saphenous ablation and treatment of varicosities versus staged phlebectomy. J Vasc Surg Venous Lymphat Disord 2017; 5 (01) 134-137
14 Carradice D, Mekako AI, Hatfield J, Chetter IC. Randomized clinical trial of concomitant or sequential phlebectomy after endovenous laser therapy for varicose veins. Br J Surg 2009; 96 (04) 369-375
15 Theivacumar NS, Dellagrammaticas D, Mavor AID, Gough MJ. Endovenous laser ablation: does standard above-knee great saphenous vein ablation provide optimum results in patients with both above- and below-knee reflux? A randomized controlled trial. J Vasc Surg 2008; 48 (01) 173-178
16 Obi AT, Reames BN, Rook TJ. et al; Michigan Vein Health Program. Outcomes associated with ablation compared to combined ablation and transilluminated powered phlebectomy in the treatment of venous varicosities. Phlebology 2016; 31 (09) 618-624
17 Gibson K, Gunderson K. Liquid and foam sclerotherapy for spider and varicose veins. Surg Clin North Am 2018; 98 (02) 415-429
18 Mann MW. Sclerotherapy: it is back and better. Clin Plast Surg 2011; 38 (03) 475-487 , vii
19 Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol 1987; 17 (2, Pt 1): 167-182
20 Duffy DM. Sclerosants: a comparative review. Dermatol Surg 2010; 36 (Suppl. 02) 1010-1025
21 Yiannakopoulou E. Safety concerns for sclerotherapy of telangiectases, reticular and varicose veins. Pharmacology 2016; 98 (1-2): 62-69
22 Watson JJ, Mansour MA. Cosmetic sclerotherapy. J Vasc Surg Venous Lymphat Disord 2017; 5 (03) 437-445
23 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27 (01) 58-60
24 Biegeleisen HI. Telangiectasia associated with varicose veins. JAMA 1934; 102 (25) 2092
25 Willenberg T, Smith PC, Shepherd A, Davies AH. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology 2013; 28 (03) 123-131
26 Todd III KL, Wright DI. VANISH-2 Investigator Group. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2). J Vasc Surg Venous Lymphat Disord 2015; 3 (03) 258-264.e1